377 related articles for article (PubMed ID: 28024581)
1. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
[TBL] [Abstract][Full Text] [Related]
2. Effects of paclitaxel nanocrystals surface charge on cell internalization.
Choi JS; Park JS
Eur J Pharm Sci; 2016 Oct; 93():90-6. PubMed ID: 27516149
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
4. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
Choi JS; Park JS
Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
[TBL] [Abstract][Full Text] [Related]
5. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
6. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of decorated aceclofenac nanocrystals.
Park JJ; Meghani N; Choi JS; Lee BJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():206-212. PubMed ID: 27011350
[TBL] [Abstract][Full Text] [Related]
8. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
10. Impact of surface modification in BSA nanoparticles for uptake in cancer cells.
Choi JS; Meghani N
Colloids Surf B Biointerfaces; 2016 Sep; 145():653-661. PubMed ID: 27289306
[TBL] [Abstract][Full Text] [Related]
11. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
[TBL] [Abstract][Full Text] [Related]
12. Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells.
Choi JS; Park JS
Colloids Surf B Biointerfaces; 2017 Nov; 159():139-150. PubMed ID: 28783505
[TBL] [Abstract][Full Text] [Related]
13. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
14. Cube-shaped theranostic paclitaxel prodrug nanocrystals with surface functionalization of SPC and MPEG-DSPE for imaging and chemotherapy.
Guo F; Shang J; Zhao H; Lai K; Li Y; Fan Z; Hou Z; Su G
Colloids Surf B Biointerfaces; 2017 Dec; 160():649-660. PubMed ID: 29031225
[TBL] [Abstract][Full Text] [Related]
15. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y
ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919
[TBL] [Abstract][Full Text] [Related]
16. Hydroxypropyl Beta Cyclodextrin as a Potential Surface Modifier for Paclitaxel Nanocrystals.
Haddad R; Alrabadi N; Altaani B; Masadeh M; Li T
AAPS PharmSciTech; 2022 Aug; 23(6):219. PubMed ID: 35945468
[TBL] [Abstract][Full Text] [Related]
17. Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluation.
Tang B; Fang G; Gao Y; Liu Y; Liu J; Zou M; Cheng G
Int J Pharm; 2014 Nov; 475(1-2):416-27. PubMed ID: 25218393
[TBL] [Abstract][Full Text] [Related]
18. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
20. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
